← The library
Research only

AOD-9604

aka HGH 176-191 modified

A modified slice of growth hormone, marketed as a fat-burner.

Technically · Modified GH fragment

fat loss
AOD-9604
The vial
AOD-9604 2D molecular structure
The moleculeCID 16129617

In one sentence

A stabilized growth-hormone fragment sold as a fat-burner — popular in clinics, weak in the actual trials.

Like the tail end of HGH that supposedly only does the fat-loss part. Phase 2 said: no better than placebo.

Half-life

~30 minutes

Burns off in about 30 minutes — daily dosing.

Dosing

Daily, AM fasted

How often you take a dose

Route

SubQ

How it goes into the body

Status

Research

Sold for lab research — not approved for humans

Education only. Many compounds discussed are research chemicals not approved for human use in the US. This is not medical advice — consult a licensed physician.

What it is

Take a small piece of growth hormone, tweak it so it lasts longer, and you get AOD-9604. It's heavily marketed at weight-loss clinics as a fat-burner with none of the downsides of full HGH. The actual trial result? Same weight loss as placebo.

The full technical answer

Synthetic fragment of growth hormone (residues 176–191) modified for stability. Marketed as a fat-loss peptide; no proven body composition effect in human trials.

How it works

The idea is that this little piece of HGH tells your body to burn fat without raising IGF-1 or messing with blood sugar. Sounds clean in theory. In a placebo-controlled trial, it didn't actually move the scale.

The full technical answer

Theorized to stimulate lipolysis without affecting IGF-1 or blood glucose. Mechanism studies primarily in animal/in-vitro models.

ExtracellularInside the cellLipolysis pathwayReceptorpeptidedownstream signaling
Receptors hit: Lipolysis pathway. The peptide binds the receptor on the cell surface, triggering downstream signaling inside the cell.

What the research says

Phase 2b trial (Heffernan 2001) showed no significant weight loss vs placebo over 12 weeks. Marketing claims exceed clinical evidence.

Sources: AOD-9604 Phase 2b

Common dosing ranges

Range
300 mcg/day common
Frequency
Daily, AM fasted
Duration
No defined cycle

Sources: PubMed

How to take it

Practical guidance synthesized from clinical protocols, FDA labels, and clinician interviews. Always cross-check with a prescribing physician.

Best time of day

AM, fasted. Most protocols schedule it 30+ minutes before breakfast.

With food or fasted

Fasted is preferred — like other GH-fragment claims, insulin/carbs may blunt the effect.

How long to cycle

8–12 week cycles. No defined "best" cycle protocol since clinical evidence is so thin.

When to get off

No measurable fat loss after 8 weeks → stop, since trials don't support it either.

Administration

SubQ

Side effects

Common

  • Reportedly minimal

Serious / theoretical

  • Unknown long-term

Sources: PubMed

Further reading & listening

Where the experts go deeper.

Curated from the PeptideFacts expert directory — vetted YouTube channels, podcasts, books, and communities. No anecdote-only or supplier-affiliated picks.

Often compared